JERSEY CITY, N.J., June 15, 2022 /PRNewswire/ -- InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on "Global Cell Therapy Packaging Products and Services Market (Therapy (T-cell Therapies, Dendritic Cell Vaccines, Stem Cell Therapies, NK Cell Therapies, and Other ATMPs), Package Engineering Design (Primary Packaging and Secondary Packaging), Scale of Operation (Clinical and Commercial))- By Trends, Industry Competition Analysis, Revenue and Forecast Till 2030"
According to the latest research by InsightAce Analytic, the global cell therapy packaging products and services market is expected to reach US$ 1,252.14 Million in 2030, recording a promising CAGR of 20.32% during the period of 2022-2030.
Request for Sample Pages:https://www.insightaceanalytic.com/request-sample/1265
Cell therapy aims to modify genetic material to treat different chronic diseases. Cell and gene therapy is the most significant medical advance in recent history. The increasing investments by key players in the development of promising therapies and advanced packaging technologies are anticipated to fuel the market growth over the forecast period.
Biopharmaceutical companies are investing in developing and manufacturing new customizable "patient-centered medicine" and modernizing their supply chains. Although biopharmaceutical firms' primary focus is on the drug product (DP) research and production and delivery methods (e.g., syringes), packaging and labelling are crucial to ensuring product quality and efficacy. The packaging of cell and gene therapy products must maintain closure integrity and product stability and allow simple access to the product while remaining functional during heat and mechanical loads experienced. The packaging must be designed to endure cryogenic temperatures without compromising the quality of the biological material or its longevity. For instance, In February 2022, Sharp, a leading provider in contract packaging and clinical supply services, has designed new purpose-built production suites to fulfil the rising demand from producers of gene treatments for dedicated and specialized packaging capacity. The innovative secondary packaging by Sharp aims to give an appropriate environment for tackling the challenges of gene treatments, notably at low temperatures and distribution in cold and ultra-cold supply chains. In summary, packaging technology and engineering, graphics, and labelling design are vital components of the development and marketing of gene and cell therapy programs.
Major driving factors of the cell therapy packaging products and services market are the increasing need for cell therapies, advancements in packaging and labelling, high prevalence of cancer diseases. Furthermore, advanced medical technologies, the rising trend of outsourcing in the healthcare industry, and the ongoing efforts of service providers to further improve their portfolios are enhancing the growth of the cell therapy packaging products and services market. However, the high cost of manufacturing systems, lack of standard therapy protocols, and complex procedures are restraining the growth of this market.
Geographically, the North America region is the primary revenue holder of this market due to rising awareness about cell and gene therapies, increasing government investments in the research and development of cell therapies, stringent regulations and an increasing number of human chronic diseases. On the other hand, Europe will also dominate the market during the forecast period due to advancements in the biopharmaceutical field and stringent regulations. The Asia-Pacific market is expected to grow faster in the future due to the growing cell therapy manufacturing industries and the adoption of new technologies.
Major key players in the cell therapy packaging products and services market are Almac, Catalent Pharma Solutions, Cryoport Systems, Core Cryolab Inc., Yourway, Lufthansa Cargo, Saint-Gobain Life Sciences, Thermo Fisher Scientific, Sharp, West Pharmaceutical Services, Chart Industries Inc., and Other Prominent Players. Leading manufacturers in this field focus on novel therapy innovations, partnerships, collaborations, mergers, and agreements. These strategies will help to boost their growth opportunities in this market.
Key Developments:
- In Feb 2022, Cell and gene therapy developers may now access Thermo Fisher Scientific's new integrated commercial packaging and distribution capabilities, which are designed to facilitate a seamless transition from the clinic to commercial launch for patients in the United States and Europe. Patheon Commercial Packaging Services for Cell and Gene Therapies (CGT) is an end-to-end solution that combines GMP storage, serialisation, ultracold and cryogenic packaging, and worldwide distribution to support the logistical strategies of developers.
- In February 2020, Almac and Pfizer revealed steps to slash gene therapy labelling times. In April 2018, Almac Group, the global contract pharmaceutical development and manufacturing organization, expanded its US commercial packaging capabilities at its Audubon, PA facility.
- In October 2020, Thermo Fisher Scientific announced the launch of its Gibco CTS Rotea Counterflow Centrifugation System, a modular, closed-cell therapy processing system that enables scalable, cost-effective cell therapy development and manufacturing. The CTS Rotea system is the first Gibco instrument for cell therapy processing applications and facilitates workflows from research through GMP clinical development and commercial manufacturing.
Curious about this latest version of report? Enquire Before Buying @ https://www.insightaceanalytic.com/enquiry-before-buying/1265
Market Segments
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on Therapy
- T-cell Therapies
- Dendritic Cell Vaccines
- Stem Cell Therapies
- NK Cell Therapies
- Other ATMPs
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on Package Engineering Design
- Primary Packaging
- Secondary Packaging
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on Scale of Operation
- Clinical
- Commercial
Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2030 based on Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
North America cell therapy packaging products and services market revenue (US$ Million) by Country, 2022 to 2030
- U.S.
- Canada
Europe cell therapy packaging products and services market revenue (US$ Million) by Country, 2022 to 2030
- Germany
- France
- Italy
- Spain
- Russia
- Rest of Europe
Asia Pacific cell therapy packaging products and services market revenue (US$ Million) by Country, 2022 to 2030
- India
- China
- Japan
- South Korea
- Australia & New Zealand
Latin America cell therapy packaging products and services market revenue (US$ Million) by Country, 2022 to 2030
- Brazil
- Mexico
- Rest of Latin America
Middle East & Africa cell therapy packaging products and services market revenue (US$ Million) by Country, 2022 to 2030
- GCC Countries
- South Africa
- Rest of Middle East & Africa
For Customized Information @ https://www.insightaceanalytic.com/customisation/1265
Other Related Reports Published by InsightAce Analytic:
Global Cell and Gene Therapy Bioassay Services Market
Global Vaccine Cold Chain Logistics Market
Global Cell and Gene Therapy Drug Delivery Devices Market
Why should buy this report:
- To receive a comprehensive analysis of the prospects for global cell therapy packaging products and services market
- To receive industry overview and future trends of global cell therapy packaging products and services market
- To analyse the cell therapy packaging products and services market drivers and challenges
- To get information about the cell therapy packaging products and services market size value (US$ Mn) forecast till 2030
- Major Investments, Mergers & Acquisition in global cell therapy packaging products and services market industry
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Contact US:
InsightAce Analytic Pvt. Ltd.
Tel.: +1 718 593 4405
Email: info@insightaceanalytic.com
Site Visit: www.insightaceanalytic.com
Follow Us on LinkedIn @ bit.ly/2tBXsgS
Follow Us On Facebook @ bit.ly/2H9jnDZ
Logo: https://mma.prnewswire.com/media/1729637/InsightAce_Analytic_Logo.jpg
